Table 1 Baseline characteristics of the two HCM-AF and HCM-no-AF groups
Total (n = 141) | HCM-AF (n = 35) | HCM-no-AF (n = 106) | P value | |
|---|---|---|---|---|
Age (± sd) | 51 (17) | 52 (18) | 51 (17) | 0.63 |
Male (%) | 74 (52) | 11 (31) | 63 (59) | 0.004* |
BMI (± sd) | 27.1 (4.8) | 27 (5.4) | 27.1 (4.5) | 0.93 |
BSA (± sd) | 1.8 (0.2) | 1.8 (0.2) | 1.8 (0.2) | 0.76 |
Family History of HCM | 57 (40) | 16 (46) | 41 (39) | 0.46 |
NSVT | 7 (5) | 3 (9) | 4 (4) | 0.26 |
Syncope | 17 (12) | 7 (20) | 10 (11) | 0.1 |
T2DM | 19 (13) | 4 (11) | 15 (14) | 0.68 |
AH | 46 (33) | 7 (20) | 39 (37) | 0.07 |
Dyslipidemia | 21 (15) | 4 (11) | 17 (16) | 0.51 |
CKD | 4 (3) | 1 (3) | 3 (3) | 0.99 |
COPD | 8 (6) | 2 (6) | 6 (6) | 0.99 |
CAD | 7 (5) | 0 (-) | 7 (7) | 0.12 |
PM | 6 (4) | 3 (9) | 3 (3) | 0.15 |
ICD | 23 (16) | 7 (20) | 16 (15) | 0.50 |
Myomectomy | 27 (19) | 8 (23) | 19 (18) | 0.52 |
Alcoholization | 2 (1) | 0 (-) | 2 (2) | 0.41 |
LVOTO | 49 (35) | 10 (4) | 39 (37) | 0.38 |
HCM Risk Score | 1.9 (1) | 2.1 (1.3) | 2.2 (1.1) | 0.86 |
AF | ||||
Paroxymsal | 24 (17) | 24 (69) | - | |
Persistent | 7 (5) | 7 (20) | - | |
Permanent | 4 (3) | 4 (11) | - | |